Subscribe to Newsletter

Comprehensive Genomic Profiling with SureSelect Cancer CGP Assay

With the Agilent SureSelect Cancer CGP assay, a targeted, pan-cancer panel based on next-generation sequencing (NGS) technology, you’ll have access to the most clinically relevant and up-to-date biomarker content by detecting key classes of somatic alterations. Have confidence in high-performance results optimized with error-correcting molecular barcodes, convenient enzymatic fragmentation and minimum sample input. The workflow solution is configurable to meet the needs of your lab with options to incorporate sample QC, automation, and data analysis solutions.

>> Download brochure as a PDF

Find out more on Agilent's website here

>Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Pathologist site. It’s FREE!

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine